Cancer BiologybioRxivPreprint
CDK19 is a Regulator of Triple-Negative Breast Cancer Growth
Robert W. Hsieh, Angera H. Kuo, Ferenc A. Scheeren…·Michael F. Clarke
This study identifies CDK19 as a therapeutic target for TNBC by showing its role in tumor growth and metastasis, with minimal impact on normal cells.
DOI 10.1101/317776